|This symposium discusses research into the therapeutic use of MDMA, both historically and presently. In the period following its rediscovery in the 1970s, MDMA soon gained a reputation as a powerful adjunct for psychotherapy. In 1985 in the US (and 1988 in the Netherlands), MDMA was scheduled as a controlled substance, effectively stemming all research and most therapeutic use. Since the mid 2000s, research and clinical interest into the therapeutic potential of MDMA has increased significantly and MDMA-assisted psychotherapy is on track to become a licensed treatment in several years. What do we know about the therapeutic use of this substance? Who may benefit from treatment, and what would such treatment look like? How can MDMA-assisted psychotherapy be integrated into mental health care? These questions, and others, will be addressed by several international experts in the field.
16:10 Prof. dr. Gemma Blok – Legal therapeutic use of MDMA in the 70s and 80s
16:40 Prof. Torsten Passie – Observations on MDMA-assisted psychotherapy in clinical practice
17:10 Rick Doblin, PhD – Positioning MDMA-assisted psychotherapy in mainstream health care
**18:00 – 19:00 BREAK AND DINNER**
19:00 Tijmen Bostoen, MD – Therapeutic applications of MDMA for the treatment of PTSD
19:20 Prof. dr. Eric Vermetten – Educating and training licensed MDMA therapists
20:10 An interview with Rick Doblin & Torsten Passie on the past and future of MDMA, followed by Q&A
21:00 **End of programme **
Hosted by OPEN, APRA, MAPS Europe, LUMC / Arq
A buffet dinner with sandwiches, fruit, and soft drinks is included in the ticket price.